Studies related to General Oxidation and Arginine

The Effect Of Oral L-arginine Supplementation On Fasting Glucose, HbA1c, Nitric Oxide And Total Antioxidant Status In Diabetic Patients With Atherosclerotic Peripheral Arterial Disease Of Lower Extremities

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 38
Gender Both Genders
Age Range 45-64, 65+
Body Types Obese, Overweight
Notes for this study:
6g of L-Arginine daily (in three doses of 2g) for 2 months in persons with both diabetes and peripheral artery disease was able to increase total antioxidant capacity (normally impaired with diabetes) and nitric oxide metabolites, but failed to benefic HbA1c and fasting blood glucose.